Patients treated after ≥2 lines showed response rates similar to those observed in the whole cohort, although differences in the odds of ORR and CRR for liso-cel compared to axi-cel did not reach statistical significance ( supplemental Figure 6 ).
← all excerpts
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma.
1
—
—